Clinical Trial Update: Hydroxyurea for the Treatment of Patients With Sickle Cell Anemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for hydroxyurea in sickle cell anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Anemia | Phase 2 | Status: COMPLETED